Guo-qiang Z. Pan
107 West Wen Hua Road
Jinan, 250012, China
Jinan, 250012, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Hypoxia drives ferroptosis resistance and immunosuppression in hepatocellular carcinoma by inducing UBASH3B-mediated glutamine metabolism reprogramming and CXCL8 expression.
Journal: Redox biology
Published: May 22, 2026
Response to "expanding the clinical and Immunogenomic relevance of SAMD1 in hepatocellular carcinoma".
Journal: Metabolism: clinical and experimental
Published: June 23, 2025
Targeting SAMD1 enhances the effect of anti-PD-1 plus lenvatinib therapy in hepatocellular carcinoma by increasing ferroptosis sensitivity and immune response.
Journal: Metabolism: clinical and experimental
Published: March 14, 2025
Targeting FAM111B attenuates mitophagy and increases the sensitivity to lenvatinib treatment by increasing MFN2 stability in hepatocellular carcinoma.
Journal: Cell death & disease
Published: February 25, 2025
Hypoxia-Induced Creatine Uptake Reprograms Metabolism to Antagonize PARP1-Mediated Cell Death and Facilitate Tumor Progression in Hepatocellular Carcinoma.
Journal: Cancer research
Published: January 23, 2025
Correction: MALAT1/ mir-1-3p mediated BRF2 expression promotes HCC progression via inhibiting the LKB1/AMPK signaling pathway.
Journal: Cancer cell international
Published: June 08, 2024
Comparison of tenofovir versus entecavir for preventing hepatocellular carcinoma in chronic hepatitis B patients: an umbrella review and meta-analysis.
Journal: Journal of cancer research and clinical oncology
Published: June 01, 2024
Thyroid hormones inhibit tumor progression and enhance the antitumor activity of lenvatinib in hepatocellular carcinoma via reprogramming glucose metabolism.
Journal: Cell death discovery
Published: April 25, 2024
The effect of age, sex, and eastern cooperative oncology group performance status on the efficacy and safety of immune checkpoint inhibitors in patients with hepatocellular carcinoma: a systematic review and meta-analysis.
Journal: Expert review of anticancer therapy
Published: April 16, 2024
Is there a place for endoscopic management in post-cholecystectomy iatrogenic bile duct injuries?
Journal: World journal of gastrointestinal surgery
Published: December 27, 2023
Performance of GALAD score and serum biomarkers for detecting NAFLD-related HCC: a systematic review and network meta-analysis.
Journal: Expert review of gastroenterology & hepatology
Published: November 06, 2023
Role of hepatitis B core-related antigen in predicting the occurrence and recurrence of hepatocellular carcinoma in patients with chronic hepatitis B: A systemic review and meta-analysis.
Journal: Journal of gastroenterology and hepatology
Published: October 26, 2023
Last Updated: 09/26/2026